Why vaccine patents complicate responses to the Covid crisis
The collaboration necessary to create a vaccine at record speed could lead to legal battles over the parties involved in inventing the COVID vaccine. The outcome could yet again change the course of the pandemic.
UP NEXT
NOW PLAYING: News
Why vaccine patents complicate responses to the Covid crisis
CNBC
UP NEXT
-
The Pre-Markets Rundown: May 19, 2022
CNBC
-
How Love, Bonito sustains its social media presence
-
Love, Bonito on opportunities in the Asian diaspora market
-
There's a growing urgency to adopt sustainable farming practices in Australia
-
The big question on Europe's plan to ditch Russian energy is who's going to pay for it: World Energy Council
-
The first 'red line' for video surveillance tech is human rights, says video technology software firm
-
Invesco strategist explains why it's still a 'good environment' for borrowing despite rising rates
-
Covid drugs haven't been a major contributor to our revenue, says Indian pharmaceutical firm
-
E-commerce in Southeast Asia is still at a 'very, very nascent stage,' says venture capital firm
-
Singapore Airlines has a 'first mover advantage' thanks to the country's reopening: Industry expert
-
AIA names the industries in Asia that it finds attractive
-
Inflation in Australia could be nearing its peak, says HSBC
-
S&P Global Ratings cuts its growth forecasts for the U.S., Europe and China
-
IG reports on why Afghan military collapsed so quickly after U.S. withdrawal
-
Jim Cramer outlines some of the biggest headwinds to the stock market's recovery
-
Russian soldier pleads guilty in Ukraine's first war crimes trial
